W. Heindel et al., P-31-MR SPECTROSCOPY OF THE HUMAN LIVER - SPECTRAL HINTS ON HEPATIC LYMPHOMA INFILTRATION, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 167(1), 1997, pp. 62-70
P-31-MR spectroscopy of the human liver - spectral hints on hepatic ly
mphoma infiltration. Purpose: To evaluate whether phosphorus magnetic
resonance spectroscopy (P-31-MRS) enables a non-invasive detection of
liver involvement in systemic diseases like Hodgkin's lymphoma. Materi
als and methods: Using a clinical 1.5 Tesla whole-body MR system image
-guided localised phosphorus MR spectra from the anatomically defined
volumes of interests were measured. A combination of surface coil, adi
abatic excitation pulse and modified image-selected in vivo spectrosco
py (ISIS)-sequence was applied. The spectroscopy data were evaluated q
uantitatively with a time-domain fit programme using non-linear optimi
sation algorithms to quantify peak areas. After establishment of the e
x; amination protocol, 22 healthy volunteers and 13 patients with susp
ected lymphoma infiltration of the liver were examined. Results: Liver
spectra of patients suffering from lymphoma infiltration differed sig
nificantly from spectra of persons with normal liver: 1. The peak area
ratio of phosphomonoesters (PME) to beta-NTP was elevated in all pati
ents with histologically confirmed liver lymphoma. 2. Patients sufferi
ng from Hodgkin's disease with specific or unspecific liver infiltrati
on (n=7) could be differentiated from patients without liver involveme
nt. In case of infiltrated liver, the peak area ratio PME to beta-NTP
was increased, and the pH value was shifted to lower values. Unambiguo
us differentiation between non-specific (n=3) and specific (n=4) infil
tration of the liver was not possible. 3. In patients after cytostatic
treatment (n=3), an increase of the peak area ratio of inorganic phos
phate to beta-NTP was observed. Conclusion: Our preliminary results in
dicate that P-31-MRS can yield pointers to liver involvement in patien
ts with systemic diseases such as Hodgkin's disease, which may be hard
ly detected by imaging methods.